Cite

HARVARD Citation

    George, D. et al. (2021). A prospective trial of abiraterone acetate plus prednisone in Black and White men with metastatic castrate‐resistant prostate cancer. Cancer. 127 (16), pp. 2954-2965. [Online]. 
  
Back to record